Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Interest Expenses (2016 - 2022)

BioRestorative Therapies (BRTX) has disclosed Interest Expenses for 8 consecutive years, with $17284.0 as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Interest Expenses changed N/A year-over-year to $17284.0, compared with a TTM value of $17284.0 through Jun 2023, changed N/A, and an annual FY2018 reading of $177286.0, changed N/A over the prior year.
  • Interest Expenses was $17284.0 for Q3 2022 at BioRestorative Therapies, up from $12311.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $17284.0 in Q3 2022 and bottomed at $12311.0 in Q3 2020.